Explore 3 Stock Ideas & Industry Insights Download Free Report

News

U.S. Markets Advance Amid Fed Rate Cut Hopes, Geopolitical Calm, and Tech Strength

Index Update:U.S. stock futures rose, with all major indexes up around 0.4%, following a record close for the Nasdaq 100. Gains were driven by easing geopolitical tensions, optimism over potential Fed rate cuts, and strong tech earnings. Reports that President Trump may soon announce …

Team Kalkine | 26 June 2025

Goldman Sachs Upgrades Ameren Corp. (NYSE:AEE) to Neutral, Raises Price Target to USD100

Goldman Sachs revised its outlook on Ameren Corp. (NYSE:AEE) on Tuesday, upgrading the stock fromSell to Neutraland raising its 12-month price target fromUSD91.00 to USD100.00. The investment bank’s reassessment comes in response to an improved fundamental picture for Ameren’s Missouri operations and a diminished …

Team Kalkine | 26 June 2025

JP Morgan Upgrades Yum Brands (NYSE:YUM) to Overweight, Sets USD162 Price Target

JP Morgan upgradedYum Brands Inc. (NYSE:YUM)toOverweightfromNeutral, citing an improved valuation, consistent global unit expansion, and solid free cash flow generation as key drivers behind the rating change. The investment bank also lifted its price target for Yum toUSD162 by December 2026, suggesting upside potential …

Team Kalkine | 26 June 2025

Roth Capital Upgrades Electronic Arts (NASDAQ:EA) to Buy, Hikes Target to USD 185

Roth Capital has upgradedElectronic Arts Inc. (NASDAQ:EA)fromNeutraltoBuy, raising its 12-month price target toUSD185, up from the previous USD175. The broker attributes the upgrade to growing confidence in EA’s execution capabilities and the potential fordouble-digit earnings growth over the next three fiscal years.

Team Kalkine | 25 June 2025

Citizens JMP Upgrades Capital Southwest (NASDAQ:CSWC) to Market Outperform

Citizens JMP Securities has upgradedCapital Southwest Corporation (NASDAQ:CSWC)fromMarket PerformtoMarket Outperform, assigning a newprice target of USD25.00. The rating change comes in response to what the research firm described as “one of the best quarterly results” from the business development company (BDC) in the first …

Team Kalkine | 25 June 2025

U.S. Markets Daily Wrap-Up: Stocks Rally, Oil Rebounds, and Fed Policy in Focus

Index Update:U.S. stocks rallied on Tuesday, with the S&P 500 and Nasdaq nearing record highs amid easing geopolitical tensions as a ceasefire between Israel and Iran appeared to hold. The Dow also posted strong gains. Oil prices extended their decline, falling nearly 20% from …

Team Kalkine | 25 June 2025

ECARX (Nasdaq: ECX) Expands into Robotics with Lidar Partnership; Targets Mass Production by 2026

ECARX Holdings Inc. (Nasdaq: ECX), known for its automotive intelligence systems, announced a strategic partnership with a leading global developer of robotic lawn mowers to deploy its proprietary solid-state lidar technology in non-automotive applications. The agreement represents a notable pivot for ECARX as it …

Team Kalkine | 25 June 2025

Evotec SE (Nasdaq: EVO) Joins NURTuRE-AKI Consortium to Advance Kidney Disease Research

Evotec SE (Frankfurt Stock Exchange: EVT; Nasdaq: EVO) has announced its participation in the NURTuRE-AKI consortium, a longitudinal research initiative focused on acute kidney injury (AKI) and its progression to chronic kidney disease (CKD). The study targets both adult and pediatric cardiac surgery patients …

Team Kalkine | 25 June 2025

WISeKey (Nasdaq: WKEY) Expands Satellite Access via Astrocast Agreement to Strengthen IoT Coverage

WISeKey International Holding Ltd (SIX: WIHN; Nasdaq: WKEY) announced that its subsidiary, WISeSat.Space, has signed a strategic collaboration agreement with Astrocast, a nanosatellite IoT network operator based in Switzerland. The agreement grants WISeSat access to Astrocast’s operational Low Earth Orbit (LEO) satellite constellation, significantly …

Team Kalkine | 25 June 2025

InspireMD (Nasdaq: NSPR) Receives FDA PMA Approval for CGuard Prime

InspireMD, Inc. (Nasdaq: NSPR), a medical technology company focused on stroke prevention, has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for its CGuard Prime Carotid Stent System. The approval allows the commercial launch of the device in the U.S. …

Team Kalkine | 25 June 2025